AETHLON MEDICAL INC (AEMD (AEMD) Stock Price, Financials & Summary

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$5.10

From 52W high−82.05%

Volume86128.00

Market cap$8.28M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataOct 19, 2026

Open

$5.10

From 52W high

−82.05%

Volume

86128.00

Market cap

$8.28M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.6x

P/E (TTM)

—

RSI (14)

47.4

MomentumView details →

1D Return

+0.19%

YTD Return

−63.47%

SummaryUpdated Jun 1, 2026

Aethlon Medical, Inc. (NASDAQ:AEMD) is a medical technology company founded in 1999 and based in San Diego, California. The company went public in March 1999 and focuses on developing innovative blood filtration devices to treat life-threatening diseases. Aethlon operates as a clinical-stage company with its flagship product, the Hemopurifier, currently undergoing various clinical trials for cancer treatment and viral infections. The company has no commercial revenue from product sales and remains in the research and development phase, funded primarily through equity raises and government contracts.

Ask drillr about AETHLON MEDICAL INC (AEMD →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−0.6x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

1.6x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−133.43%

ROA (TTM)

−111.26%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

+82.08%

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

+87.63%

EBITDA YoY

+46.52%

MomentumView details →

1D Return

+0.19%

YTD Return

−63.47%

1Y Return

−81.63%

RSI (14)

47.4

vs 50D SMA

+24.94%

vs 200D SMA

−37.76%

Capital & dividendView details →

Debt/Equity

0.07x

Current Ratio

5.42x

Quick Ratio

5.42x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$4.02

EPS Surprise

0.74%

Beats (12Q)

4/12

Next Q EPS Est

−$1.71

Avg Surprise (4Q)

31.18%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−6.94M

Op. CF (TTM)

−1.90B

Next earningsNov 11, 2026 →

Latest newsMore news →

Aethlon Medical Inc. appointed Edward G. Broenniman, James B. Frakes, Nicolas Gikakis, Angela Rossetti, and Chetan S. Shah, MD, as directors effective October 1, 2026.18d ago

Aethlon Medical Inc. shares dropped on Friday, pulling back after surging more than 300% the previous day.31d ago

Similar companies

Biomerica, Inc.BMRA NeuroOne Medical Technologies CorporationNMTC Bone Biologics CorporationBBLGW Pulsenmore Ltd. Ordinary SharesPLSM enVVeno Medical CorporationNVNO Sintx Technologies, Inc.SINT Find similar companies →

Latest newsMore news →

Aethlon Medical Inc. appointed Edward G. Broenniman, James B. Frakes, Nicolas Gikakis, Angela Rossetti, and Chetan S. Shah, MD, as directors effective October 1, 2026.18d ago Aethlon Medical Inc. shares dropped on Friday, pulling back after surging more than 300% the previous day.31d ago Halper Sadeh LLC announced it is investigating whether Aethlon Medical, Inc. is obtaining a fair price for shareholders in its merger with North Immunology, Inc.32d ago